Abstract
Background
Optimal treatment of spontaneous portosystemic shunts (SPSS) during liver transplantation (LT) remains debated. We systematically reviewed the literature on definitions, treatment and outcomes of patients presenting SPSS undergoing LT.
Methods
According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we used PubMed to retrieve all studies dealing with SPSS and LT between January 1987 and January 2020. The primary endpoints were definitions and outcomes according to the management of SPSS (treatment vs observation).
Results
Thirteen studies detailing the management of 962 SPSS were retrieved. Hemodynamically significant SPSS were defined as those having diameter ≥ 10 mm in 41% (n = 395) of patients. SPSS were splenorenal (42%), cavo-gastric (15.2%), umbilical (7.4%), mesenterico-caval (n = 31; 3.2%), mesenterico-renal (0.1%) and unreported (31.9%), respectively. At the time of LT 372 shunts (38.7%) were treated while 590 were observed (61.3%). During a follow-up time ranging from 4 months to 5 years, the reported overall survival (OS) at 1 year was not significantly different except for one study. Portal vein anastomosis complications (i.e. reduced flow, stenosis or thrombosis) were similarly reported in observed [n = 26 (4%)] and ligated SPSS [n = 10 (2%)] (p = 0.22) but the rate of relaparotomy was significantly higher in observed SPPS (16 vs 2; p = 0.01) to rescue post LT portal vein thrombosis (n = 6) and reduced portal flow and graft dysfunction (n = 10).
Conclusions
There was a heterogeneous management of SPSS during LT in the literature. Ligation of SPPS did not reduce vascular complications neither improved survival. A randomized prospective study might contribute to identify best management of SPSS at time of LT.
Similar content being viewed by others
References
Zhou H-Y, Chen T-W, Zhang X-M, Jing Z-L, Zeng N-L, Zhai Z-H. Patterns of portosystemic collaterals and diameters of portal venous system in cirrhotic patients with hepatitis B on magnetic resonance imaging: association with Child-Pugh classifications. Clin Res Hepatol Gastroenterol. 2015;39(3):351–358. https://doi.org/10.1016/j.clinre.2014.09.012
Vidal-González J, Quiroga S, Simón-Talero M, Genescà J. Spontaneous portosystemic shunts in liver cirrhosis: new approaches to an old problem. Ther Adv Gastroenterol. 2020;13:1756284820961287. https://doi.org/10.1177/1756284820961287
Rodriguez EA, Perez R, Zhang N, et al. Clinical outcomes of portosystemic shunts on the outcome of liver transplantation. Liver Transplant. 2020;26(5):693–701. https://doi.org/10.1002/lt.25710
Zardi EM, Uwechie V, Caccavo D, et al. Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance. J Gastroenterol. 2009;44(1):76–83. https://doi.org/10.1007/s00535-008-2279-1
Chikamori F, Nishida S, Selvaggi G, et al. Effect of liver transplantation on spleen size, collateral veins, and platelet counts. World J Surg. 2010;34(2):320–326. https://doi.org/10.1007/s00268-009-0314-x
Kim H, Yoon KC, Lee K-W, et al. Tips and pitfalls in direct ligation of large spontaneous splenorenal shunt during liver transplantation. Liver Transplant. 2017;23(7):899–906. https://doi.org/10.1002/lt.24783
De Carlis L, Del Favero E, Rondinara G, et al. The role of spontaneous portosystemic shunts in the course of orthotopic liver transplantation. Transpl Int. 1992;5(1):9–14. https://doi.org/10.1007/BF00337182
Sanada Y, Mizuta K, Urahashi T, et al. Impact of posttransplant portosystemic shunts on liver transplantation. World J Surg. 2012;36(10):2449–2454. https://doi.org/10.1007/s00268-012-1692-z
Esquivel CO, Klintmalm G, Iwatsuki S, et al. Liver transplantation in patients with patent splenorenal shunts. Surgery. 1987;101(4):430–432
Saks K, Jensen KK, McLouth J, et al. Influence of spontaneous splenorenal shunts on clinical outcomes in decompensated cirrhosis and after liver transplantation. Hepatol Commun. 2018;2(4):437–444. https://doi.org/10.1002/hep4.1157
Gomez Gavara C, Bhangui P, Salloum C, et al. Ligation versus no ligation of spontaneous portosystemic shunts during liver transplantation: audit of a prospective series of 66 consecutive patients. Liver Transplant. 2018;24(4):505–515. https://doi.org/10.1002/lt.24999
Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16(8):943–949. https://doi.org/10.1002/lt.22091
Castillo-Suescun F, Oniscu GC, Hidalgo E. Hemodynamic consequences of spontaneous splenorenal shunts in deceased donor liver transplantation. Liver Transpl. 2011;17(8):891–895. https://doi.org/10.1002/lt.22304
Allard M, Akamatsu N, Kokudo T, et al. Clinical significance of spontaneous portosystemic shunts in living donor liver transplantation. Liver Transpl. 2021;27(1):77–87. https://doi.org/10.1002/lt.25798
Ikegami T, Shirabe K, Nakagawara H, et al. Obstructing spontaneous major shunt vessels is mandatory to keep adequate portal inflow in living-donor liver transplantation. Transplantation. 2013;95(10):1270–1277. https://doi.org/10.1097/TP.0b013e318288cadc
Takatsuki M, Baimakhanov Z, Soyama A, et al. Obstructing spontaneous major shunt vessels might not be mandatory to maintain adequate portal inflow in living donor liver transplantation. Transplantation. 2014;97(9):e52-53. https://doi.org/10.1097/TP.0000000000000092
Kisaoglu A, Dandin O, Demiryilmaz I, et al. A single-center experience in portal flow augmentation in liver transplantation with prior large spontaneous splenorenal shunt. Transplant Proc. 2020. https://doi.org/10.1016/j.transproceed.2020.05.015
Golse N, Bucur PO, Faitot F, et al. Spontaneous splenorenal shunt in liver transplantation: results of left renal vein ligation versus renoportal anastomosis. Transplantation. 2015;99(12):2576–2585. https://doi.org/10.1097/TP.0000000000000766
Golse N, Mohkam K, Rode A, et al. Surgical management of large spontaneous portosystemic splenorenal shunts during liver transplantation: splenectomy or left renal vein ligation? Transplant Proc. 2015;47(6):1866–1876. https://doi.org/10.1016/j.transproceed.2015.06.019
Lee S-G, Moon D-B, Ahn C-S, et al. Ligation of left renal vein for large spontaneous splenorenal shunt to prevent portal flow steal in adult living donor liver transplantation. Transplant Int. 2007;20(1):45–50. https://doi.org/10.1111/j.1432-2277.2006.00392.x
Wang Q, Lv Y, Bai M, et al. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. J Hepatol. 2017;67(3):508–516. https://doi.org/10.1016/j.jhep.2017.05.006
Brems JJ, Hiatt JR, Klein AS, et al. Effect of a prior portasystemic shunt on subsequent liver transplantation. Ann Surg 1989;209(1):51–56. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1493874/. Accessed 5 Jan 2021.
de Franchis R, Baveno VI. Faculty expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–752. https://doi.org/10.1016/j.jhep.2015.05.022
Ito K, Akamatsu N, Ichida A, et al. Splenectomy is not indicated in living donor liver transplantation. Liver Transplant. 2016;22(11):1526–1535. https://doi.org/10.1002/lt.24489
Linares I, Goldaracena N, Rosales R, et al. Splenectomy as flow modulation strategy and risk factors of de novo portal vein thrombosis in adult-to-adult living donor liver transplantation. Liver Transplant. 2018;24(9):1209–1220. https://doi.org/10.1002/lt.25212
Nagao Y, Akahoshi T, Uehara H, et al. Balloon-occluded retrograde transvenous obliteration is feasible for prolonged portosystemic shunts after living donor liver transplantation. Surg Today. 2014;44(4):633–639. https://doi.org/10.1007/s00595-013-0535-3
Shigeta T, Kasahara M, Sakamoto S, et al. Balloon-occluded retrograde transvenous obliteration for a portosystemic shunt after pediatric living-donor liver transplantation. J Pediatr Surg. 2011;46(6):e19-22. https://doi.org/10.1016/j.jpedsurg.2011.03.077
Kim JH, Ko G-Y, Sung K-B, et al. Transvenous variceal embolization during or after living-donor liver transplantation to improve portal venous flow. J Vasc Intervent Radiol. 2009;20(11):6
Funding
No funding.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflicts of interest
Caterina Cusumano, Stefano Gussago, Martina Guerra, Chloe Paul, François Faitot, Philippe Bachellier and Pietro Addeo have no conflict of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cusumano, C., Gussago, S., Guerra, M. et al. Management of spontaneous portosystemic shunts at the time of liver transplantation: treatment or observation? Results of a systematic review. Hepatol Int 16, 983–992 (2022). https://doi.org/10.1007/s12072-022-10377-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12072-022-10377-w